GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

IBO · Jun 30, 2026

IMPACT BIOMEDICAL INC.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 1[email protected]

Inspectable configuration

State dimensions

Filing0001493152-26-036601General Corporate

Operating cash generationRAWCurrent state valid · history insufficient

Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

15666.67% · OPTIONAL · NOT_ENOUGH_HISTORY

Revenue growthRAWCurrent state valid · history insufficient

Evidence method

Yoy · gp.fundamentals.revenue

-57.14% · CORE · NOT_ENOUGH_HISTORY

Inventory pressureRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.inventory_revenue_ratio

2066.67% · OPTIONAL · NOT_ENOUGH_HISTORY

Gross marginRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.gross_margin

66.67% · CORE · NOT_ENOUGH_HISTORY

Operating marginRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.operating_margin

-23400.00% · CORE · NOT_ENOUGH_HISTORY

R&D intensityRAWCurrent state valid · history insufficient

Evidence method

Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue

2533.33% · OPTIONAL · NOT_ENOUGH_HISTORY

SBC intensityRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

0.00% · OPTIONAL · NOT_ENOUGH_HISTORY

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History3 statesHistory building

Jun 30, 20250/6 normalizedLevel 1 Sep 30, 20250/6 normalizedLevel 1 Jun 30, 20260/7 normalizedLevel 1

Period transition

What moved in the state?

Cash Generation Increased

Previous: -6628.57%
Current: 15666.67%
Delta: 22295.24%

Inventory Pressure Increased

Previous: 900.00%
Current: 2066.67%
Delta: 1166.67%

Profitability Increased

Previous: -32700.00%
Current: -23400.00%
Delta: 9300.00%

R And D Intensity Increased

Previous: 657.14%
Current: 2533.33%
Delta: 1876.19%

Sbc Intensity Decreased

Previous: 20571.43%
Current: 0.00%
Delta: -20571.43%

Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.

Research Graph

Related governed research

Compared To · Pharmaceutical Preparations peers →Transitioned To · IBO CASH_GENERATION_INCREASED →Transitioned To · IBO INVENTORY_PRESSURE_INCREASED →Transitioned To · IBO PROFITABILITY_INCREASED →Transitioned To · IBO R_AND_D_INTENSITY_INCREASED →Transitioned To · IBO SBC_INTENSITY_DECREASED →

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.